TY - JOUR
T1 - Detection of the Sanfilippo type B syndrome using radiolabelled oligosaccharides as substrates for the estimation of α-N-acetylglucosaminidase
AU - Hopwood, John J.
AU - Elliott, Helen
N1 - Funding Information:
This work was supportedb y grants from the ResearchT rust of the Adelaide Children’s Hospital and the National Health and Medical ResearchC ouncil of Australia.
PY - 1982/3/26
Y1 - 1982/3/26
N2 - 1. 1. The following radiolabelled disaccharides were prepared from heparin and evaluated as substrates for α-N-acetylglucosaminidase present in cultured skin fibroblasts: O-(α-2-acetamido-2-deoxy-d-glucopyranosyl)-(l → 4)-l-[6,3H]idose (GlcNAc-Ido), O-(α-2-acetamido-2-deoxy-d-glucopyranosyl)-(l '→ 4)-1,6 anhydro-l-6,3H] idose (GlcNAc-anldo), O-(α-2-acetamido-2-deoxy-d-glucopyranosyl)-(1→ 4)-L-[6,3H] idose 2-sulfate (GlcNAc-Ido(OS)), O-(α-2-acetamido-2-deoxy-d-glucopyranosyl)-(l → 3)-l-[6,3H] idonic acid (GlcNAc-IdOA). 2. 2. α-N-Acetylglucosaminidase activity assessed with GlcNAc-IdOA was 12 times higher than the values obtained using GlcNAc-Ido, GlcNAc-anldo and GlcNAc-Ido(OS). Less than 5% of normal activity resulted when these substrates were incubated with fibroblasts from Sanfilippo B patients. These results demonstrate that a C6 carboxyl group on the adjacent residue to the N-acetylglucosaminide moiety is an important structural requirement in the mechanism of action or binding of α-N-acetylglucosaminidase toward α-linked N-acetylglucosaminide residues. The presence of a C2 sulfate group on the adjacent residue had no effect on enzyme activity. 3. 3. α-N-Acetylglucosaminidase activity in leucocyte and fibroblast homogenates assayed using GlcNAc-IdOA as substrate clearly distinguished Sanfilippo B patients from normal controls, and Sanfilippo A, C and D patients.
AB - 1. 1. The following radiolabelled disaccharides were prepared from heparin and evaluated as substrates for α-N-acetylglucosaminidase present in cultured skin fibroblasts: O-(α-2-acetamido-2-deoxy-d-glucopyranosyl)-(l → 4)-l-[6,3H]idose (GlcNAc-Ido), O-(α-2-acetamido-2-deoxy-d-glucopyranosyl)-(l '→ 4)-1,6 anhydro-l-6,3H] idose (GlcNAc-anldo), O-(α-2-acetamido-2-deoxy-d-glucopyranosyl)-(1→ 4)-L-[6,3H] idose 2-sulfate (GlcNAc-Ido(OS)), O-(α-2-acetamido-2-deoxy-d-glucopyranosyl)-(l → 3)-l-[6,3H] idonic acid (GlcNAc-IdOA). 2. 2. α-N-Acetylglucosaminidase activity assessed with GlcNAc-IdOA was 12 times higher than the values obtained using GlcNAc-Ido, GlcNAc-anldo and GlcNAc-Ido(OS). Less than 5% of normal activity resulted when these substrates were incubated with fibroblasts from Sanfilippo B patients. These results demonstrate that a C6 carboxyl group on the adjacent residue to the N-acetylglucosaminide moiety is an important structural requirement in the mechanism of action or binding of α-N-acetylglucosaminidase toward α-linked N-acetylglucosaminide residues. The presence of a C2 sulfate group on the adjacent residue had no effect on enzyme activity. 3. 3. α-N-Acetylglucosaminidase activity in leucocyte and fibroblast homogenates assayed using GlcNAc-IdOA as substrate clearly distinguished Sanfilippo B patients from normal controls, and Sanfilippo A, C and D patients.
UR - http://www.scopus.com/inward/record.url?scp=0020042564&partnerID=8YFLogxK
U2 - 10.1016/0009-8981(82)90079-1
DO - 10.1016/0009-8981(82)90079-1
M3 - Article
C2 - 6802523
AN - SCOPUS:0020042564
SN - 0009-8981
VL - 120
SP - 77
EP - 86
JO - Clinica Chimica Acta
JF - Clinica Chimica Acta
IS - 1
ER -